Literature DB >> 1559158

Transient global amnesia. A case control study.

T P Melo1, J M Ferro, H Ferro.   

Abstract

A case control study of transient global amnesia (TGA), transient ischaemic attacks (TIA) and normal controls is described. Each of the 51 TGA patients, selected between January 1985 and March 1990, was compared with four controls (two TIAs and two normals) for the presence of vascular risk factors (hypertension, diabetes, smoking habits, cholesterol, triglycerides and haematocrit levels, heart disease, previous stroke), previous TGA, migraine, psychiatric illness and recent head trauma. Patients with TGA had less diabetes, hypercholesterolaemia and hypertriglyceridaemia than TIA. TGA subjects had significantly more hypertension (odds ratio = 3.31) and migraine (odds ratio = 8.67) than normal controls. During a mean of 17.4 mths of follow-up (range 1-96 mths), three subjects had recurrent TGA, one sustained a TIA and a minor stroke, but none had seizures. Thrombo-embolism and epilepsy are unlikely to be the cause of this benign disorder. The role is stressed of appropriate precipitants, including haemodynamic changes, and of individual susceptibility (of which migraine is probably a marker) in the genesis of TGA.

Entities:  

Mesh:

Year:  1992        PMID: 1559158     DOI: 10.1093/brain/115.1.261

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  15 in total

1.  A Case of Transient Global Amnesia: A Review and How It May Shed Further Insight into the Neurobiology of Delusions.

Authors:  David R Spiegel; Aidan L Mccroskey; Branden A Deyerle
Journal:  Innov Clin Neurosci       Date:  2016-04-01

2.  Transient global amnesia in a patient with high and persistent levels of antiphospholipid antibodies.

Authors:  Norberto Ortego-Centeno; José Luis Callejas-Rubio; Miguel Guerrero Fernández; Miguel Gómez Camello
Journal:  Clin Rheumatol       Date:  2005-10-06       Impact factor: 2.980

3.  Long-Term Outcome in Patients With Transient Global Amnesia: A Population-Based Study.

Authors:  Julieta E Arena; Robert D Brown; Jay Mandrekar; Alejandro A Rabinstein
Journal:  Mayo Clin Proc       Date:  2017-02-06       Impact factor: 7.616

4.  Changes in cerebral blood flow and vasoreactivity in response to acetazolamide in patients with transient global amnesia.

Authors:  Y Sakashita; M Kanai; T Sugimoto; S Taki; M Takamori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-11       Impact factor: 10.154

5.  An image is not always worth a thousand words: an image mimic of transient global amnesia.

Authors:  Pedro Coelho; Miguel Schön; Pedro Nascimento Alves; Ana Catarina Fonseca; Teresa Pinho E Melo
Journal:  Neurol Sci       Date:  2021-01-18       Impact factor: 3.307

Review 6.  Forgetting the Unforgettable: Transient Global Amnesia Part I: Pathophysiology and Etiology.

Authors:  Marco Sparaco; Rosario Pascarella; Carmine Franco Muccio; Marialuisa Zedde
Journal:  J Clin Med       Date:  2022-06-12       Impact factor: 4.964

7.  Are brief or recurrent transient global amnesias of epileptic origin?

Authors:  T P Melo; J M Ferro; T Paiva
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

8.  Transient epileptic amnesia--a clinical update and a reformulation.

Authors:  N Kapur
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-11       Impact factor: 10.154

Review 9.  Migraine in transient global amnesia: a meta-analysis of observational studies.

Authors:  Ioannis Liampas; Athanasios S Siouras; Vasileios Siokas; Zisis Tsouris; Dimitrios Rikos; Alexandros Brotis; Athina-Maria Aloizou; Metaxia Dastamani; Efthimios Dardiotis
Journal:  J Neurol       Date:  2021-01-02       Impact factor: 4.849

10.  Transient Global Amnesia (TGA): Influence of Acute Hypertension in Patients Not Adapted to Chronic Hypertension.

Authors:  Andreas Rogalewski; Anne Beyer; Anja Friedrich; Jorge Plümer; Frédéric Zuhorn; Isabell Greeve; Randolf Klingebiel; Friedrich G Woermann; Christian G Bien; Wolf-Rüdiger Schäbitz
Journal:  Front Neurol       Date:  2021-07-08       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.